Search results
-
Facial Changes and Skin Conditions in Patients on GLP-1 Receptor Agonists
Has anyone observed alterations in facial appearance or skin condition—such as facial fullness, skin texture changes, or other dermatological effects—in patients using GLP-1 receptor agonists like Wegovy (semaglutide 2.4 mg once weekly) or Ozempic (semaglutide 0.5 mg to 2 mg weekly)? I’ve heard...- Kristen McGahey
- Thread
- Replies: 11
- Forum: Semaglutide (Ozempic, Wegovy, Rybelsus)